Beijing Centergate Technologies (holding) Co., Ltd.

Shenzhen Stock Exchange 000931.SZ

Beijing Centergate Technologies (holding) Co., Ltd. Gross Profit Margin for the year ending December 31, 2023: 57.90%

Beijing Centergate Technologies (holding) Co., Ltd. Gross Profit Margin is 57.90% for the year ending December 31, 2023, a 0.51% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Beijing Centergate Technologies (holding) Co., Ltd. Gross Profit Margin for the year ending December 31, 2022 was 57.61%, a 11.79% change year over year.
Beijing Centergate Technologies (holding) Co., Ltd. Gross Profit Margin for the year ending December 31, 2021 was 51.53%, a -8.09% change year over year.
Beijing Centergate Technologies (holding) Co., Ltd. Gross Profit Margin for the year ending December 31, 2020 was 56.07%, a 3.02% change year over year.
Beijing Centergate Technologies (holding) Co., Ltd. Gross Profit Margin for the year ending December 31, 2019 was 54.42%, a 1.84% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Shenzhen Stock Exchange: 000931.SZ

Beijing Centergate Technologies (holding) Co., Ltd.

CEO	Mr. Zhanjun Hou
IPO Date	July 12, 1999
Location	China
Headquarters	Pengrun Building
Employees	2,434
Sector	Real Estate
Industries Health Care REITs Industrial REITs

Description

Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical production and sales, construction, real estate development, and property management businesses in China and internationally. The company offers huasu west-ground iodine, fesser phenylcycline hydrochloride, bosu fuma acid bisolol, yuanji beni flat hydrochloric acid, naloxone hydrochloride, five plus biochemical, and aramol quramado tablets and capsules. It also provides mucous membrane repair and oral health care products, including toothpaste, mouthwash, spray, dental equipment, and other oral care products for ulcers, burns, mechanical damage, and postoperative repair; and fruit enzymes, imported fungella enzymes, functional probiotics, and soda and other edible grade raw materials. In addition, the company invests in software technology, communications and electronic engineering, biomedicine, and life sciences and other fields. Beijing Centergate Technologies (holding) Co., Ltd. was founded in 1999 and is based in Beijing, China.

Key trends

Past 5 years